Moriyama T, Tanaka K, Iwasaki C et al (2014) Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan. PLoS One 9:e91756. https://doi.org/10.1371/journal.pone.0091756

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wyatt RJ, Kritchevsky SB, Woodford SY et al (1995) IgA nephropathy: long-term prognosis for pediatric patients. J Pediatr 127:913–919. https://doi.org/10.1016/s0022-3476(95)70027-7

Article  CAS  PubMed  Google Scholar 

Yata N, Nakanishi K, Shima Y et al (2008) Improved renal survival in Japanese children with IgA nephropathy. Pediatr Nephrol 23:905–912. https://doi.org/10.1007/s00467-007-0726-5

Article  PubMed  PubMed Central  Google Scholar 

Suzuki H, Kiryluk K, Novak J et al (2011) The pathophysiology of IgA nephropathy. J Am Soc Nephrol 22:1795–1803. https://doi.org/10.1681/ASN.2011050464

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bagchi S, Mani K, Swamy A et al (2021) Supportive management of IgA Nephropathy with renin-angiotensin blockade, the AIIMS primary IgA Nephropathy Cohort (APPROACH) Study. Kidney Int Rep 6:1661–1668. https://doi.org/10.1016/j.ekir.2021.02.018

Article  PubMed  PubMed Central  Google Scholar 

Coppo R, Amore A, Gianoglio B et al (1993) Angiotensin II local hyperreactivity in the progression of IgA nephropathy. Am J Kidney Dis 21:593–602. https://doi.org/10.1016/s0272-6386(12)80031-x

Article  CAS  PubMed  Google Scholar 

Tanaka S, Ninomiya T, Katafuchi R et al (2016) The effect of renin-angiotensin system blockade on the incidence of end-stage renal disease in IgA nephropathy. Clin Exp Nephrol 20:689–698. https://doi.org/10.1007/s10157-015-1195-y

Article  CAS  PubMed  Google Scholar 

Tunnicliffe DJ, Reid S, Craig JC et al (2024) Non-immunosuppressive treatment for IgA nephropathy. Cochrane Database Syst Rev 2:CD003962. https://doi.org/10.1002/14651858.CD003962.pub3

Article  PubMed  Google Scholar 

Stevens PE, Levin A, Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members (2013) Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med 158:825–830. https://doi.org/10.7326/0003-4819-158-11-201306040-00007

Article  PubMed  Google Scholar 

Kobayashi Y, Fujii K, Hiki Y et al (1986) Steroid therapy in IgA nephropathy: a prospective pilot study in moderate proteinuric cases. Q J Med 61:935–943

CAS  PubMed  Google Scholar 

Kobayashi Y, Fujii K, Hiki Y et al (1988) Steroid therapy in IgA nephropathy: a retrospective study in heavy proteinuric cases. Nephron 48:12–17. https://doi.org/10.1159/000184861

Article  CAS  PubMed  Google Scholar 

Pozzi C, Bolasco PG, Fogazzi GB et al (1999) Corticosteroids in IgA nephropathy: a randomised controlled trial. Lancet 353:883–887. https://doi.org/10.1016/s0140-6736(98)03563-6

Article  CAS  PubMed  Google Scholar 

Rauen T, Eitner F, Fitzner C et al (2015) Intensive supportive care plus Immunosuppression in IgA nephropathy. N Engl J Med 373:2225–2236. https://doi.org/10.1056/NEJMoa1415463

Article  CAS  PubMed  Google Scholar 

Lv J, Zhang H, Wong MG et al (2017) Effect of oral methylprednisolone on clinical outcomes in patients with IgA nephropathy: the TESTING randomized clinical trial. JAMA 318:432–442. https://doi.org/10.1001/jama.2017.9362

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coppo R, Lofaro D, Camilla RR et al (2017) Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort. Pediatr Nephrol 32:139–150

PubMed  Google Scholar 

Lv J, Wong MG, Hladunewich MA et al (2022) Effect of oral methylprednisolone on decline in kidney function or kidney failure in patients with IgA nephropathy: the TESTING randomized clinical trial. JAMA 327:1888–1898. https://doi.org/10.1001/jama.2022.5368

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schwartz GJ, Muñoz A, Schneider MF et al (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637. https://doi.org/10.1681/ASN.2008030287

Article  PubMed  PubMed Central  Google Scholar 

Chi XH, Li GP, Wang QS et al (2017) CKD-EPI creatinine-cystatin C glomerular filtration rate estimation equation seems more suitable for Chinese patients with chronic kidney disease than other equations. BMC Nephrol 18:226. https://doi.org/10.1186/s12882-017-0637-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group (2021) KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int 100(4S):S1–S276. https://doi.org/10.1016/j.kint.2021.05.021

Article  Google Scholar 

de Simone G, Mancusi C, Hanssen H et al (2022) Hypertension in children and adolescents. Eur Heart J 43:3290–3301. https://doi.org/10.1093/eurheartj/ehac328

Article  PubMed  Google Scholar 

Trimarchi H, Barratt J, Cattran DC et al (2017) Oxford Classification of IgA nephropathy 2016: an update from the IgA nephropathy classification working group. Kidney Int 91:1014–1021. https://doi.org/10.1016/j.kint.2017.02.003

Article  PubMed  Google Scholar 

Shima Y, Nakanishi K, Hama T et al (2020) Crescentic IgA nephropathy in children. Pediatr Nephrol 35:1005–1014. https://doi.org/10.1007/s00467-020-04483-w

Article  PubMed  Google Scholar 

Tesar V, Troyanov S, Bellur S et al (2015) Corticosteroids in IgA Nephropathy: a retrospective analysis from the VALIGA Study. J Am Soc Nephrol 26:2248–2258. https://doi.org/10.1681/ASN.2014070697

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mitsnefes MM, Laskin BL, Dahhou M et al (2013) Mortality risk among children initially treated with dialysis for end-stage kidney disease, 1990–2010. JAMA 309:1921–1929. https://doi.org/10.1001/jama.2013.4208

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cambier A, Boyer O, Deschenes G et al (2020) Steroid therapy in children with IgA nephropathy. Pediatr Nephrol 35:359–366. https://doi.org/10.1007/s00467-018-4189-7

Article  PubMed  Google Scholar 

Fellström BC, Barratt J, Cook H et al (2017) Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial. Lancet 389:2117–2127. https://doi.org/10.1016/S0140-6736(17)30550-0

Article  PubMed  Google Scholar 

Vivarell M, Samuel S, Coppo R et al (2025) IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis. Pediatr Nephrol 40:533–569. https://doi.org/10.1007/s00467-024-06502-6

Article  Google Scholar 

Stangou M, Ekonomidou D, Giamalis P et al (2011) Steroids and azathioprine in the treatment of IgA nephropathy. Clin Exp Nephrol 15:373–380. https://doi.org/10.1007/s10157-011-0415-3

Article  CAS  PubMed  Google Scholar 

Pozzi C (2016) Treatment of IgA nephropathy. J Nephrol 29:21–25. https://doi.org/10.1007/s40620-015-0248-3

Article  CAS  PubMed  Google Scholar